Previous Article | Next Article ![]()
Journal of Bacteriology, June 2003, p. 3499-3507, Vol. 185, No. 12
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.12.3499-3507.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Committee on Microbiology, University of Chicago, Chicago, Illinois 60637
Received 3 January 2003/ Accepted 26 March 2003
|
|
|---|
|
|
|---|
Yersinia type III secretion is activated by environmental signals (42, 59, 79). During bacterial growth in laboratory media, yersiniae secrete most, but not all, Yop proteins upon chelation of calcium from the extracellular medium (50). When yersiniae secrete large amounts of Yop proteins, bacterial growth is slowed in the absence of calcium, a phenomenon that is referred to as the low-calcium response (Lcr) (73, 74). The critical threshold for activation is <80 µM, well below the calcium concentration in extracellular fluids of mammalian hosts (1.2 mM) but also well above the intracellular calcium concentration of mammalian cells (low nanomolar range) (45, 59). Yersiniae that adhere to the surface of mammalian cells catalyze the type III injection process (67, 68), and recent work suggested that yersiniae measure the intracellular calcium concentration in host cells (45). Bacterial growth in chemically defined media, for example, Dulbecco's minimal Eagle medium, does not lead to type III secretion, even under low-calcium conditions (45). Two additional signals, glutamate and host serum proteins, must be provided with the chemically defined media to activate the type III pathway (45).
Goguen, Yother, and Straley used Mu-d1(Ap lac) transposon mutagenesis in Y. pestis and were the first to isolate mutants that are defective in the Lcr pathway (30, 80). Wolf-Watz, Cornelis, and colleagues demonstrated that such mutations block Yop protein secretion (ysc mutations) across the bacterial envelope (2, 3, 5). Goguen et al. isolated 206 mutants, and further analysis revealed that 47 transposon insertions had occurred on the virulence plasmid, 16 insertions were accompanied by loss of the virulence plasmid, and 143 insertions were mapped to the bacterial chromosome (30). Subsequent research focused on the mutations in the virulence plasmid. DNA sequencing and mutational analysis has revealed the genes for a type III secretion pathway on the virulence plasmid; however, the nature of the mutations on the bacterial chromosome has hitherto not been described (19). Knockout mutations of ysc genes, which encode the secretion machinery, lead to an lcr phenotype, abolishing type III secretion and allowing bacterial growth at 37°C even in the absence of calcium (19). Knockout mutations in lcrE (yopN), tyeA, sycN, yscB, and lcrG result in a calcium-blind temperature-sensitive growth phenotype, as the mutant yersiniae massively secrete Yop proteins at 37°C even in the presence of 5 mM calcium (14, 15, 27, 36, 38, 80). Knockout mutations in yopD, lcrH, and lcrQ (yscM1 and yscM2 in Y. enterocolitica) yield a different phenotype in which some, but not all, Yop proteins are secreted in the presence of calcium (4, 6, 64, 72).
Recent work suggested that yopN, tyeA, sycN, yscB, lcrG, lcrV, yopD, lcrH, yscM1, and yscM2 encode negative regulators of the type III pathway (45). One subset, yopD, lcrH, yscM1, and yscM2, is required to prevent the expression of yop genes by a posttranscriptional control mechanism that targets the 5' untranslated regions of yop mRNAs (11). Mutations that block the function of any one of these four genes bypass the requirement for glutamate to activate type III secretion (45). The Yersinia type III pathway secretes YopD into the extracellular medium by a mechanism that requires binding of YopD to LcrH in the bacterial cytoplasm (4, 77). YscM1 and YscM2, on the other hand, are injected into the cytoplasm of eukaryotic cells, a transport reaction that requires not only Ysc proteins but also SycH, a cytoplasmic protein that binds to YscM1 and YscM2 and whose overexpression results in the activation of the Lcr (10, 11, 78). Thus, one can view YopD, LcrH, YscM1, YscM2, and SycH as regulators that activate the type III pathway in response to an extracellular glutamate signal by promoting distinct transport reactions and derepression of a posttranscriptional control mechanism for yop genes (61).
A partially overlapping subset of regulatory genes, yopN, tyeA, sycN, yscB, lcrG, and lcrV, affect the response to calcium (23, 24, 39, 47). YopN is initiated into the type III pathway even in the presence of calcium. This process requires SycN and YscB, which form a heterodimer that binds to YopN between residues 15 and 100 (14, 23). TyeA functions as a repressor of YopN secretion in the presence of calcium and binds a more distal portion of YopN (residues 100 to 215) (14, 15). A drop in calcium concentration results in the injection of YopN into eukaryotic cells and the activation of the type III pathway; the regulatory factors YscB, SycN, and TyeA presumably detach from YopN and continue to reside in the bacterial cytoplasm (14, 44). In this model of regulation, YopN acts as a modifier of the type III machinery that hinders the transport of specific sets of Yop proteins in the presence of calcium.
The mechanism by which LcrG regulates yop gene expression is not yet known (70). LcrG binds to LcrV, an antirepressor that is transported by the type III pathway; initiation of LcrV into the type III pathway is dependent on its binding to LcrG (54, 55, 69). Environmental glutamate and serum proteins trigger secretion of LcrV into the extracellular medium (45). In contrast to the case for most other Yops, the removal of calcium blocks LcrV transport, resulting in intrabacterial sequestration of LcrG by LcrV and in the activation of Lcr (47). Knockout mutations in lcrG or yopN bypass the Yersinia requirement for a calcium signal to activate the type III pathway without affecting bacterial dependence on glutamate or serum protein signals (45).
The Yersinia type III pathway can be viewed as a developmentally controlled secretion system, requiring signal input from the environment as well as signal transduction cascades that activate bacterial defense against the host's immune system. In an attempt to identify Yersinia proteins that receive or transmit such signals, we isolated mutants defective in the low-calcium response. One of these mutations, ttsA, mapped to a chromosomal gene encoding a polytopic membrane protein. The ttsA mutant yersiniae were completely defective in low-calcium-induced type III secretion of Yop proteins and were impaired in bacterial motility and in the expression of flagellar filament subunits. These defects were restored by complementation with plasmid-encoded wild-type ttsA. Mutation of the lcrG gene in a ttsA mutant strain restored the type III secretion of Yop proteins, although the double mutant strain secreted Yops in the presence and absence of calcium, similar to the case for mutants that are defective in lcrG gene function alone (24). Together these results suggest that ttsA encodes a regulatory factor of the Yersinia type III pathway.
|
|
|---|
Y. enterocolitica strain KUM1 (
lcrD) and MC2 (
lcrG) have been described elsewhere (13, 24). The E. coli S17-1 strain (25) harboring the suicide plasmid pLC28 (16) or pMC8 (24) was used to construct the
lcrG mutation in Y. enterocolitica NG15307 (
ttsA). Allelic exchange following mating of E. coli S17-1 and Y. enterocolitica strains has been previously described (16).
Transposon mutagenesis.
Y. enterocolitica W22703(pKD29) was grown overnight in 50 ml of TBMM (1% tryptone, 0.5% NaCl, 0.2% maltose, 10 mM MgSO4) supplemented with 1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) and 20 µg of chloramphenicol per ml. Cultures were centrifuged at 10,000 x g for 10 min, and the bacterial sediment was suspended in 10 mM MgSO4. Cells were mixed with
NK1098 at a multiplicity of infection of 10 and incubated at room temperature for 15 min. Samples were shifted to 37°C and incubated for an additional 90 min. The reaction mixtures were mixed in 3 ml of melted top agar at 50°C and poured over tryptic soy agar (TSA) plates supplemented with 12 µg of tetracycline per ml and 5 mM CaCl2. Plates were allowed to solidify and were then incubated at 37°C for 2 days. Colonies were streaked onto TSA with 12 µg of tetracycline per ml (TSATET) and onto TSA treated with 20 mM sodium oxalate (TSAOX). TSATET plates were incubated at 26°C for 2 days, whereas TSAOX plates were incubated at 37°C overnight (14 h). Y. enterocolitica strain W22703 (wild type) was used as a positive control, and KUM1 (
lcrD, type III secretion mutant) was used as a negative control for the Lcr growth phenotype.
Yop secretion assay. Overnight cultures of yersiniae were diluted 1:20 into 4 ml of fresh tryptic soy broth (TSB) supplemented with either 5 mM calcium or 5 mM EGTA. Cultures were incubated for 2 h at 26°C and then switched to 37°C and incubated for an additional 3 h. Bacterial cultures were centrifuged at 15,000 x g for 15 min. The culture supernatant was separated from the bacterial sediment (pellet). Proteins in both fractions were precipitated with ice-cold 10% trichloroacetic acid (TCA). Samples were centrifuged at 15,000 x g for 15 min, and the precipitated sediments were washed for 15 min on ice with acetone. Samples were again centrifuged at 15,000 x g for 15 min and air dried after aspiration of most of the supernatant. Proteins were suspended in 50 µl of 500 mM Tris-HCl (pH 8.0)-4% sodium dodecyl sulfate (SDS) and boiled for 5 min. Sample buffer, i.e., 50 µl of YSB (3 M urea, 0.0625 M Tris-HCl, 4% ß-mercaptoethanol, 2% SDS, 20% glycerol [pH 6.8]), was added to each sample. Proteins were separated by SDS-10 or 15% polyacrylamide gel electrophoresis (PAGE) and analyzed by immunoblotting with specific rabbit antisera with chemiluminescent detection.
Flagellin secretion assay. Overnight cultures of yersiniae were diluted 1:50 into 30 ml of T medium (1% tryptone) and incubated at 26°C for 6 h. After centrifugation at 8,000 x g for 10 min, culture supernatants were separated from cell pellets. The protein in both fractions was precipitated with ice-cold 10% TCA. Samples were centrifuged at 15,000 x g for 20 min, and the precipitate was washed with ice-cold acetone. Samples were again centrifuged at 15,000 x g for 15 min. Supernatants were aspirated, and the pellets were allowed to air dry. Proteins were suspended in 100 µl of YSB separated by SDS-15% PAGE, and analyzed by immunoblotting with specific mouse antisera with chemiluminescent detection.
Antisera. The coding sequence for ttsA379-661 was PCR amplified with abutted NdeI and BamHI restriction sites by using TtsACyNde (5'-AACATATGGGTGCGCAAAGCCAGCAG-3') and TtsACyBam (5'-AAGGATCCGAGTGTCACGATATCCGGTT-3'), and the product was cloned into pET16b (Novagen) cut with the same enzymes. The recombinant plasmid was transformed into E. coli BL21(DE3). Expression of six-histidyl-tagged polypeptide was induced with 1 mM IPTG, and the polypeptide was purified by Ni-nitrilotriacetic acid affinity chromatography. The purified polypeptide was mixed with complete Freund's adjuvant and injected subscapularly into rabbits for antibody production. Mouse monoclonal antibody 15D8 recognizes E. coli flagellin and cross-reacts with Yersinia flagellin (Igen International).
Motility assays. Yersinia strains were grown in TSB at 26°C with aeration in a roller drum at 50 rpm overnight. Two microliters of culture (106 cells) was spotted onto the center of T medium plates (1% tryptone, 0.35% Difco agar). The plates were incubated at 26°C for 16 h and examined for motility (growth) by capturing images on an alpha imager system.
Electron microscopy. Bacteria were grown on motility agar (1% tryptone, 0.35% Difco agar) overnight at 26°C, scooped off the plates with a wire loop, and suspended in phosphate-buffered saline. Five microliters of sample was applied to grids, negatively stained with 1% uranyl acetate, and examined by electron microscopy with a Philips CM120 transmission electron microscope.
Mouse infections. BALB/c adult female mice were injected intraperitoneally with 0.1 ml of a solution containing 100 mg of iron dextran per ml and 5 mg of desferrioxamine B mesylate per ml. The next day, overnight bacterial cultures were diluted 1:30 in fresh TSB and incubated at 26°C for 3 h. The optical density at 600 nm was measured, and cultures were diluted in sterile phosphate-buffered saline to concentrations ranging from 103 to 109 per 0.1 ml and injected intraperitoneally into 10 mice for each dilution. Aliquots of the diluted cultures were also plated on TSA to determine the CFU injected into mice. Infected mice were observed for 5 days at 3-h intervals. Yersinia-infected animals exhibiting ruffled fur, weight loss, immobility, and labored respiration were judged to suffer from acute lethal infection and were euthanatized according to institutional guidelines and recommendations for euthanasia by the American Veterinary Medical Association. The 50% acute disease dose was determined from a 10-fold series of bacterial dilutions administered to 10 mice per dilution (63).
|
|
|---|
NK1098 carries a selectable tetRA marker within the inverted repeats of a mini-Tn10 transposon, while its transposase gene is located immediately adjacent to the mobile element (41). Following
NK1098 infection of a suitable host that does not replicate the bacteriophage, mini-Tn10 may be mobilized and inserted into host DNA. Coliphage
cannot adsorb to Y. enterocolitica because these microbes express a structurally distinct LamB maltoporin (43). The E. coli lamB gene (49) was cloned into the low-copy-number plasmid vector pHSG576 (76), and the recombinant plasmid pKD29 was transformed into Y. enterocolitica W22703. Transformants were selected on TSA supplemented with chloramphenicol and examined for
NK1098 absorption and plaque formation. Y. enterocolitica W22703(pKD29) adsorbed
NK1098; however, infection did not result in plaque formation, suggesting that the Yersinia strain does not support lytic replication of
NK1098 (data not shown). After
NK1098 absorption on Y. enterocolitica W22703(pKD29), tetracycline-resistant colonies arose on agar plates (TSATET) at a frequency of 10-7, suggesting that the injection of
NK1098 DNA and transposon insertion mutagenesis had occurred. Transposon mutants were plated on agar medium in the presence of 5 mM calcium, and 27,221 colonies were examined for a temperature-resistant phenotype on medium lacking calcium (TSAOX) at 37°C. One hundred sixty-eight mutants that displayed a defect in the Lcr were isolated, as these strains formed colonies at 37°C on TSAOX. The mutants were analyzed by Southern hybridization to determine whether the mini-Tn10 had inserted into plasmid or chromosomal DNA. The transposon insertions were mapped further by using PCR amplification and direct sequencing of the amplified DNA. Most of the mini-Tn10 insertions that led to Lcr defects occurred on the virulence plasmid (92%); 68 insertions were mapped to 17 different genes (virF, virG, lcrD, lcrE, lcrF, sycN, yscB, yscC, yscD, yscF, yscI, yscJ, yscN, yscP, yscR, yscU, and yscY). Of these mutations, 40 mapped to identical sites in virG (1), lcrF (79), and yscU (3), suggesting that the mini-Tn10 of
NK1098 has some insertion site bias. Eight transposon insertions mapped to the bacterial chromosome, one of which carried an insertion in a hitherto-unidentified Yersinia gene that was named ttsA (for type three secretion A) (Fig. 1A). Blast searches revealed that ttsA is 49% similar to igaA, a Salmonella enterica gene that is required for growth attenuation within cultured fibroblasts (12). Further, Proteus mirabilis umoB, which is 43% similar to igaA and 42% similar to ttsA, is required for flhDC activity and bacterial swarming on agar plates, a phenotype that requires flagellar motility (26, 29).
![]() View larger version (49K): [in a new window] |
FIG. 1. Insertion of mini-Tn10 in ttsA abolishes type III secretion of Yop proteins by Y. enterocolitica W22703. (A) Organization of genes and predicted transcriptional start sites for the Y. enterocolitica W22703 genome sequence encoding ttsA. (B) Yersinia cultures, i.e., the wild-type parent strain Y. enterocolitica W22703 or the ttsA mutant NG15307 without and with plasmid-encoded ttsA (pNG7), were grown at 37°C in TSB supplemented with 5 mM calcium chloride (+ Ca2+) or 5 mM EGTA (- Ca2+). Cultures were centrifuged, and the supernatant (lanes S) was separated from the bacterial sediment (pellet) (lanes P). Proteins in both fractions were precipitated with TCA and separated by SDS-15% PAGE. After electrotransfer to a polyvinylidene difluoride membrane, the blot was stained with specific rabbit antisera ( YopD, YopE, and RpoA), followed by chemiluminescence detection.
|
ttsA encodes a presumptive polytopic membrane protein of 715 amino acids. The SOSUI transmembrane algorithm (35) predicts four transmembrane helices with the topology shown in Fig. 2A. By using PCR amplification with specific primers, the coding sequence for a portion of ttsA (codons 379 to 661) was cloned into the expression vector pET16b, and the recombinant plasmid was transformed into E. coli BL21(DE3) (75). After overexpression of the recombinant gene product via IPTG-induced T7 RNA polymerase, TtsA379-661 was purified from crude cell lysates by affinity chromatography on nickel-nitrilotriacetic acid and injected into rabbits to raise specific antiserum. Proteins in crude cell lysates were separated by SDS-PAGE and analyzed by immunoblotting (Fig. 2B). Anti-TtsA revealed a 70-kDa immunoreactive species in crude lysates of the wild-type strain Y. enterocolitica W22703 as well as the lcrD (yscV) mutant strain KUM1 (Fig. 2B). Mini-Tn10 insertion into ttsA in NG15307 abolished the immunoreactive signal generated by anti-TtsA serum (Fig. 2B). The signal was restored by transformation of NG15307 with plasmid-encoded wild-type ttsA (Fig. 2B) Further, the TtsA signal of plasmid-complemented NG15307 was significantly stronger than that of the wild-type strain, consistent with the notion that ttsA expression from multicopy plasmids is increased due to a gene dosage effect (Fig. 2B).
![]() View larger version (42K): [in a new window] |
FIG. 2. Mini-Tn10 insertion abolishes the expression of ttsA, a constitutively expressed gene. (A) Predicted membrane topology of TtsA, a protein that is presumably inserted in the plasma membrane of yersiniae. (B) ttsA expression is abolished in NG15307, carrying a ttsA::mini-Tn10 mutation, and restored by plasmid transformation of the mutant with pNG7, carrying wild-type ttsA. (C) ttsA is expressed with and without induction of the type III pathway. Y. enterocolitica W22703 was grown in TSB at 26 and 37°C with and without calcium as described in the legend to Fig. 1. Proteins in the culture were precipitated with TCA and separated by SDS-PAGE, and gene expression was measured by immunoblotting with rabbit antibodies specific for TtsA ( TtsA), LcrG ( LcrG), YscD ( YscD), or RNA polymerase alpha subunit ( RpoA).
|
The ttsA::Tn10 mutant is defective in motility. Y. enterocolitica strain 8081 employs at least three different type III pathways: the virulence plasmid-encoded pathway, a chromosomally encoded pathway, and the flagellar assembly pathway. Recent work suggests that some proteins, for example, the phospholipase YplA, may be transported by more than one type III pathway (83). We wondered whether the ttsA mutant is defective for more that one type III pathway. PCR analysis of chromosomal DNAs from strains 8081 and W22703 revealed that the former, but not the latter, strain harbors genes for a chromosomal type III pathway (33) (data not shown). These results are consistent with immunoblotting experiments revealing the expression of YspA, a chromosomally encoded type III protein (28), in crude extracts of strain 8081 but not in W22703 (data not shown). We conclude that the serotype O:9 European clinical isolate Y. enterocolitica W22703 does not harbor the chromosomally encoded type III pathway reported for the American isolate Y. enterocolitica O:8 strain 8081, and this finding is consistent with another recently published report (28).
To assess the involvement of TtsA in the flagellar type III pathway, we measured bacterial motility by inoculating yersiniae on soft agar (motility) plates and observing the formation of a concentric ring surrounding the inoculation site (40, 84) (Fig. 3). The wild-type parent strain W22703 and the type III mutant strain KUM1 were both motile; however, the ttsA::Tn10 mutant NG15307 showed very little bacterial growth beyond the inoculation site (Fig. 3). A similar defect was observed for the 8081 variant lacking flhD, a mutation that is known to inhibit bacterial motility (40, 84). Transformation of NG15307 with plasmid-carried ttsA largely restored bacterial motility, although the ring of growth did not reach the same radius observed for strain W22703 or KUM1 (Fig. 3).
![]() View larger version (93K): [in a new window] |
FIG. 3. Y. enterocolitica ttsA::mini-Tn10 mutants are nonmotile. Y. enterocolitica O:9 strain W22703 (wild type) and its isogenic variants KUM1 ( lcrD), NG15307 ( ttsA), and NG15307(pNG7), as well as Y. enterocolitica O:8 strain 8081v ( flhD) with a deletion of the flagellar master regulator (negative control), were inoculated on soft agar plates, and motility was measured as the formation of a concentric growth ring after incubation at 26°C for 24 h. Agar plate images after growth were obtained with an alpha imager camera.
|
![]() View larger version (105K): [in a new window] |
FIG. 4. Y. enterocolitica ttsA::mini-Tn10 mutants display a defect in flagellar filament assembly. Y. enterocolitica O:9 strain W22703 (wild type) (A) and its isogenic variants NG15307 ( ttsA) (B) and NG15307(pNG7) (C) were grown on TSA plates, and colonies were immobilized on electron microscopy grids, stained with uranyl acetate, and viewed under a Phillips electron microscope (magnification, x6,300). Flagellar filaments were quantified on printed electron microscopy images. Bars, 1 µm.
|
![]() View larger version (18K): [in a new window] |
FIG. 5. Y. enterocolitica ttsA::mini-Tn10 mutants display a defect in the pathogenesis of mouse infections. BALB/c mice were injected with 0.1 ml of a solution containing 100 mg of iron dextran per ml and 5 mg of desferrioxamine B mesylate per ml, intraperitoneally, 24 h prior to infection (46). Y. enterocolitica strains W22703 (wild type), KUM1 ( lcrD), and NG15307 ( ttsA) were grown overnight at 26°C, diluted 1:30 into fresh TSB, and grown for 3 h. Suspensions of bacterial cells were measured for optical density at 600 nm, and bacteria were enumerated by dilution and colony formation on TSA plates. Mouse infection occurred by intraperitoneal injection of bacterial suspensions. Animal progression to acute lethal disease was monitored over time. The percent survival of animals infected with a bacterial dose of 104 CFU is plotted against the time (days) required for disease manifestation.
|
|
View this table: [in a new window] |
TABLE 1. Progression of lethal disease caused by Y. enterocolitica wild-type and ttsA mutant strains in mice
|
![]() View larger version (31K): [in a new window] |
FIG. 6. ttsA is a regulatory gene required for activation of the Yersinia type III pathway via lcrG. (A) Bacterial strains carrying mutations in the lcrG gene alone (Y. enterocolitica strain MC2 [ lcrG]) or in lcrG and ttsA (Y. enterocolitica strain KLD8 [ lcrG ttsA]) were grown in TSB at 37°C, and type III secretion was measured as described in the legend to Fig. 1. Lanes S, supernatant; lanes P, pellet. (B) The expression of ttsA was measured by immunoblotting of TCA-precipitated proteins from cultures of Y. enterocolitica strains W22703 (wild type), KUM1 ( lcrD), NG15307 ( ttsA), MC2 ( lcrG), and KLD8 ( lcrG ttsA). (C) The motility of Y. enterocolitica strains KUM1 ( lcrD), MC2 ( lcrG), and KLD8 ( lcrG ttsA) and Y. enterocolitica O:8 strain 8081v ( flhC) on soft agar medium was measured as described in the legend to Fig. 3. (D) Fractionated Yersinia cultures were examined for the synthesis and secretion of flagellin by using a monoclonal antibody.
|
|
|
|---|
To identify the genes and mechanisms that are required for the type III secretion of Y. enterocolitica, an experimental strategy that allows bacteriophage
NK1098-mediated delivery of mini-Tn10 was introduced. This scheme allows for the stable insertion of the mini-Tn10 mobile element into chromosomal and virulence plasmid genes of Y. enterocolitica. Similar to the Tn5 insertions studied by Miller and colleagues (31, 52, 82), mini-Tn10 insertions were nonrandom and occurred at preferred sites in Y. enterocolitica. Thus, the collection of 27,221 mini-Tn10 insertion mutants constructed here represented only 76 unique insertions, not a comprehensive collection. It is therefore not surprising that the search for Lcr mutants turned up only a limited number of insertional mutations in the chromosome of Y. enterocolitica. It is presumed that the number of genes involved in Lcr is significantly greater than the eight chromosomal mutations reported here.
Previous work predicted that chromosomal genes of Y. enterocolitica regulate the type III secretion genes carried by the virulence plasmid in response to environmental signals (30, 45). This hypothesis is corroborated with the identification of ttsA, encoding a membrane protein and positive regulator that activates the type III pathway by relieving the LcrG-mediated repression that occurs in the presence of calcium. This regulatory mechanism must play an important role during infection, as ttsA mutant yersiniae display a 3-log-unit reduction in virulence when measured in a mouse model of infection. Inactivation of ttsA dramatically reduced bacterial motility and flagellar assembly, suggesting that this regulatory factor activates more than one type III pathway. Several recent observations corroborate the notion of cross talk between secretion pathways, as some secretion substrates can be transported by more than one type III machine, for example, the virulence-plasmid-encoded and the flagellar pathways (81). Bleves et al. showed that flhDC, specifying the heterodimeric transcriptional activator necessary for flagellar assembly, exert a negative regulatory role on the expression and secretion of Yop proteins (7). Together these results suggest that multiple environmental signals influence the activity of type III machines, which can occur by both positive and negative regulatory mechanisms. We searched for ttsA genes in the genomes of other gram-negative bacteria and found homologs in S. enterica (50%), S. enterica serovar Typhi (50%), E. coli (49%), P. mirabilis (49%), Shigella flexneri (49%), and Y. pestis (78% identity). In contrast, Pseudomonas aeruginosa, another organism that employs type III secretion for pathogenesis, does not seem to carry ttsA. Thus, although TtsA-regulated type III secretion may occur in other gram-negative bacteria, this cannot represent a universal mechanism.
This work was supported by Public Health Service award AI42797 from the National Institute of Allergy and Infectious Diseases to O.S.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»